2025
LDL-C targets based on coronary artery calcium: advancing Figure 6 from the 2022 American college of cardiology expert consensus decision pathway
Burka S, Aneni E, Leucker T, Blaha M. LDL-C targets based on coronary artery calcium: advancing Figure 6 from the 2022 American college of cardiology expert consensus decision pathway. American Journal Of Preventive Cardiology 2025, 23: 101047. PMID: 40687938, PMCID: PMC12270811, DOI: 10.1016/j.ajpc.2025.101047.Peer-Reviewed Original ResearchExpert Consensus Decision PathwayCoronary artery calciumLDL-CArtery calciumACC Expert Consensus Decision PathwaySecondary preventionAmerican CollegeAdvanced subclinical atherosclerosisLDL-C managementLDL-C <High-risk individualsDecision pathwaysTraditional risk calculatorsSubclinical atherosclerosisPrimary preventionRisk calculatorPreventionGoal settingCalciumPatients
2024
Development and Internal-External Validation of a Post-Operative Mortality Risk Calculator for Pediatric Surgical Patients in Low- and Middle- Income Countries Using Machine Learning
Eyler Dang L, Klazura G, Yap A, Ozgediz D, Bryce E, Cheung M, Fedatto M, Ameh E. Development and Internal-External Validation of a Post-Operative Mortality Risk Calculator for Pediatric Surgical Patients in Low- and Middle- Income Countries Using Machine Learning. Journal Of Pediatric Surgery 2024, 59: 161883. PMID: 39317568, DOI: 10.1016/j.jpedsurg.2024.161883.Peer-Reviewed Original ResearchMiddle-income countriesPost-operative mortality ratePost-operative mortalityPediatric surgical patientsRisk algorithmPediatric surgery patientsMortality risk calculatorInternal-external validationSurgery patientsEligible patientsSurgical patientsCalibration slopeHospital dischargePatientsType of studyMortality rateClinical practiceCross-validated AUCIncome countriesRisk calculatorAUCMortalityDischarge statusValidation AUC1981-LB: Modeling the Impact of Semaglutide 2.4 mg in U.S. Patients with Atherosclerotic Cardiovascular Disease and BMI ≥27 kg/m2
FAURBY M, NANNA M, TOLIVER J, DOAN Q, HENRY A, SCASSELLATI SFORZOLINI T, LEVINE A, FABRICATORE A, HOUSHMAND-OEREGAARD A, MARIE NAVAR A. 1981-LB: Modeling the Impact of Semaglutide 2.4 mg in U.S. Patients with Atherosclerotic Cardiovascular Disease and BMI ≥27 kg/m2. Diabetes 2024, 73 DOI: 10.2337/db24-1981-lb.Peer-Reviewed Original ResearchNational Health and Examination SurveyAtherosclerotic cardiovascular diseaseUS adultsImpact of semaglutideMACE eventsCardiovascular diseasePotential population impactExamination SurveyPopulation impactInclusion criteriaAdverse cardiovascular eventsPotential treatment candidatesRisk reductionCensus projectionsPotential treatment effectsRisk calculatorU.S. patientsCV eventsCardiovascular eventsTrial criteriaBMIAdultsSemaglutideTherapeutic impactTreatment candidates
2023
Current use of the National Surgical Quality Improvement Program surgical risk calculator in academic surgery: a mixed-methods study
Miller S, Azar S, Farrelly J, Salzman G, Broderick M, Sanders K, Anto V, Patel N, Cordova A, Schuster K, Jones T, Kodadek L, Gross C, Morton J, Rosenthal R, Becher R. Current use of the National Surgical Quality Improvement Program surgical risk calculator in academic surgery: a mixed-methods study. Surgery In Practice And Science 2023, 13: 100173. PMID: 37502700, PMCID: PMC10373440, DOI: 10.1016/j.sipas.2023.100173.Peer-Reviewed Original ResearchNSQIP Surgical Risk CalculatorSurgical Risk CalculatorNonelective casesRisk calculatorNational Surgical Quality Improvement Program Surgical Risk CalculatorHigh-risk patientsGeneral clinical practiceSpecific clinical scenariosCross-sectional studyElectronic health recordsFrail patientsPrimary outcomeHalf of respondentsPreoperative assessmentContemporary surgical practiceClinical practiceClinical scenariosSurgical practicePast monthPatientsSurgeonsTraining statusSurrogate consentPotential interventionsHealth recordsFrank Stinchfield Award: Creation of a Patient-Specific Total Hip Arthroplasty Periprosthetic Fracture Risk Calculator
Wyles C, Maradit-Kremers H, Fruth K, Larson D, Khosravi B, Rouzrokh P, Johnson Q, Berry D, Sierra R, Taunton M, Abdel M. Frank Stinchfield Award: Creation of a Patient-Specific Total Hip Arthroplasty Periprosthetic Fracture Risk Calculator. The Journal Of Arthroplasty 2023, 38: s2-s10. PMID: 36933678, PMCID: PMC10272077, DOI: 10.1016/j.arth.2023.03.031.Peer-Reviewed Original ResearchConceptsNonmodifiable factorsMultivariate Cox regression modelComorbidity profilesEvaluate patient factorsFracture Risk CalculatorDiagnosis of osteoporosisTotal hip arthroplastyModifiable surgical factorsCox regression modelsRisk calculatorOsteoporosis medicationsSurgical approachSurgical factorsChart reviewFollow-upMultivariate analysisPatient factorsLevel IIIFemur fracturesRisk factorsPeriprosthetic femur fracturesRisk modificationRisk assessment toolOlder ageOsteoporosisAssociation between baseline cardiovascular risk and incidence rates of major adverse cardiovascular events and malignancies in patients with psoriatic arthritis and psoriasis receiving tofacitinib
Kristensen L, Strober B, Poddubnyy D, Leung Y, Jo H, Kwok K, Vranic I, Fleishaker D, Fallon L, Yndestad A, Gladman D. Association between baseline cardiovascular risk and incidence rates of major adverse cardiovascular events and malignancies in patients with psoriatic arthritis and psoriasis receiving tofacitinib. Therapeutic Advances In Musculoskeletal Disease 2023, 15: 1759720x221149965. PMID: 36777695, PMCID: PMC9909057, DOI: 10.1177/1759720x221149965.Peer-Reviewed Original ResearchMajor adverse cardiovascular eventsAtherosclerotic CV diseaseTofacitinib-treated patientsAdverse cardiovascular eventsCV diseaseASCVD riskHigh blood pressurePsoriatic arthritisHigh riskHeart-related problemsHigher baselineCardiovascular eventsBlood pressureRisk calculatorIncidence rateMore casesBaseline cardiovascular riskBaseline metabolic syndromeCardiovascular disease riskJanus kinase inhibitorDose of tofacitinibGroup of conditionsBaseline MetSPsA trialsTofacitinib exposure
2022
The Use of Race in Risk Assessment Tools Contributes to Systemic Racism
Dlott C, O’Connor M, Wiznia D. The Use of Race in Risk Assessment Tools Contributes to Systemic Racism. Journal Of Racial And Ethnic Health Disparities 2022, 10: 1-3. PMID: 36414930, DOI: 10.1007/s40615-022-01451-y.Peer-Reviewed Original ResearchConceptsTotal joint arthroplastyRisk of complicationsRisk of surgeryTotal joint replacementRisk assessment toolPerioperative riskRisk calculatorPatient raceJoint arthroplastyDecision-making discussionsJoint replacementInclusion of raceComplicationsPatientsSurgeryRiskAssessment toolReadmissionArthroplastyOsteoarthritisHipRaceSurgeonsPatient-specific Hip Arthroplasty Dislocation Risk Calculator: An Explainable Multimodal Machine Learning–based Approach
Khosravi B, Rouzrokh P, Maradit Kremers H, Larson D, Johnson Q, Faghani S, Kremers W, Erickson B, Sierra R, Taunton M, Wyles C. Patient-specific Hip Arthroplasty Dislocation Risk Calculator: An Explainable Multimodal Machine Learning–based Approach. Radiology Artificial Intelligence 2022, 4: e220067. PMID: 36523643, PMCID: PMC9745445, DOI: 10.1148/ryai.220067.Peer-Reviewed Original ResearchC-indexTotal hip arthroplastyPatient-specific riskClinical-only modelAnteroposterior pelvic radiographsClinical characteristicsClinical featuresRisk stratificationClinical dataOutcome analysisConventional radiographyImage featuresSkeletal-AppendicularPrimary total hip arthroplastyPelvic radiographsPatientsRisk calculatorStudy sampleRisk of dislocationHip arthroplastyOutcomesDiscrimination abilityDislocation incidenceSurvival modelsReticular Pseudodrusen: The Third Macular Risk Feature for Progression to Late Age-Related Macular Degeneration Age-Related Eye Disease Study 2 Report 30
Agrón E, Domalpally A, Cukras C, Clemons T, Chen Q, Lu Z, Chew E, Keenan T, Groups A. Reticular Pseudodrusen: The Third Macular Risk Feature for Progression to Late Age-Related Macular Degeneration Age-Related Eye Disease Study 2 Report 30. Ophthalmology 2022, 129: 1107-1119. PMID: 35660417, PMCID: PMC9509418, DOI: 10.1016/j.ophtha.2022.05.021.Peer-Reviewed Original ResearchConceptsLate age-related macular degenerationAge-related macular degenerationAge-related eye disease studyNeovascular age-related macular degenerationColor fundus photographsHazard ratioReticular pseudodrusenGeographic atrophyHigh riskRisk factorsSeverity ScalePresence of RPDProportional hazards regression analysisMacular Degeneration AgeClinical trial cohortIndependent risk factorEye Disease StudyHazards regression analysisImportant risk factorFundus autofluorescence imagesAMD severity scaleTrial cohortRisk calculatorClinical trialsFundus photographsIntegrating information from existing risk prediction models with no model details
Han P, Taylor J, Mukherjee B. Integrating information from existing risk prediction models with no model details. Canadian Journal Of Statistics 2022, 51: 355-374. PMID: 37346757, PMCID: PMC10281716, DOI: 10.1002/cjs.11701.Peer-Reviewed Original Research
2021
A Clinical Decision Aid to Support Personalized Treatment Selection for Patients with Clinical T1 Renal Masses: Results from a Multi-institutional Competing-risks Analysis
Psutka SP, Gulati R, Jewett MAS, Fadaak K, Finelli A, Legere L, Morgan TM, Pierorazio PM, Allaf ME, Herrin J, Lohse CM, Thompson R, Boorjian SA, Atwell TD, Schmit GD, Costello BA, Shah ND, Leibovich BC. A Clinical Decision Aid to Support Personalized Treatment Selection for Patients with Clinical T1 Renal Masses: Results from a Multi-institutional Competing-risks Analysis. European Urology 2021, 81: 576-585. PMID: 34862099, PMCID: PMC10351331, DOI: 10.1016/j.eururo.2021.11.002.Peer-Reviewed Original ResearchConceptsCancer-specific mortalityRenal cortical massesRadical nephrectomyPartial nephrectomyActive surveillancePersonalized treatment selectionClavien gradeRisk calculatorThermal ablationTreatment selectionEastern Cooperative Oncology Group performance statusClinical T1 renal massesSurgeon/hospital volumeHigh-volume referral centerInitial radical nephrectomyCharlson Comorbidity IndexCompeting-risks regressionConsecutive adult patientsGlomerular filtration rateClavien grade 3Risk of deathBody mass indexT1 renal massesRisk of mortalityClinical decision aidBuilding a Digital Health Risk Calculator for Older Women with Early-Stage Breast Cancer
Abujarad F, Wang S, Ulrich D, Mougalian S, Killelea B, Fraenkel L, Gross C, Evans S. Building a Digital Health Risk Calculator for Older Women with Early-Stage Breast Cancer. Lecture Notes In Computer Science 2021, 12780: 389-402. DOI: 10.1007/978-3-030-78224-5_27.Peer-Reviewed Original ResearchEarly-stage breast cancerOlder womenBreast cancerRadiation therapyTreatment therapiesEvidence-based treatment decisionsShared-decision modelRisk-benefit informationRisk calculatorRelative riskTreatment decisionsPatient healthDigital health toolsPatient comprehensionTherapyHealth toolsWomenCancerHealthPatientsCliniciansPrevalence of subclinical retinal ischemia in patients with cardiovascular disease – a hypothesis driven study
Long CP, Chan AX, Bakhoum CY, Toomey CB, Madala S, Garg AK, Freeman WR, Goldbaum MH, DeMaria AN, Bakhoum MF. Prevalence of subclinical retinal ischemia in patients with cardiovascular disease – a hypothesis driven study. EClinicalMedicine 2021, 33: 100775. PMID: 33842865, PMCID: PMC8020165, DOI: 10.1016/j.eclinm.2021.100775.Peer-Reviewed Original ResearchAdverse cardiovascular eventsASCVD risk scoreCardiovascular diseaseCardiovascular eventsRetinal ischemiaHealthy controlsRisk scoreCardiovascular disease risk calculatorsUC San Diego HealthAtherosclerotic cardiovascular disease risk calculatorOptical coherence tomography scansHemoglobin A1c levelsSystolic blood pressureSan Diego HealthCause of mortalityIschemic infarctSmoking historyA1c levelsBlood pressureRisk calculatorNoninvasive testsOdds ratioTomography scanAdditional biomarkersRetinal pathologyThe Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program bariatric surgical risk/benefit calculator: 30-day risk
Grieco A, Huffman KM, Cohen ME, Hall BL, Morton JM, Ko CY. The Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program bariatric surgical risk/benefit calculator: 30-day risk. Surgery For Obesity And Related Diseases 2021, 17: 1117-1124. PMID: 33773930, DOI: 10.1016/j.soard.2021.02.005.Peer-Reviewed Original ResearchConceptsBariatric Surgery AccreditationLaparoscopic adjustable gastric bandCo-morbidity remissionLaparoscopic sleeve gastrectomyAdjustable gastric bandSurgical care teamQuality Improvement ProgramLogistic regression modelsClinical data registryMBSAQIP dataLaparoscopic RouxBariatric surgeryBiliopancreatic diversionGastric bandGastric bypassSleeve gastrectomyAdult patientsDuodenal switchPostoperative riskRisk calculatorCare teamAmerican CollegeData registryExcellent calibrationRisk features
2020
The Kidney Score Platform for Patient and Clinician Awareness, Communication, and Management of Kidney Disease: Protocol for a Mixed Methods Study
Tuot DS, Crowley ST, Katz LA, Leung J, Alcantara-Cadillo DK, Ruser C, Talbot-Montgomery E, Vassalotti JA. The Kidney Score Platform for Patient and Clinician Awareness, Communication, and Management of Kidney Disease: Protocol for a Mixed Methods Study. JMIR Research Protocols 2020, 9: e22024. PMID: 33074162, PMCID: PMC7605977, DOI: 10.2196/22024.Peer-Reviewed Original ResearchChronic kidney diseaseChronic kidney disease riskINTERNATIONAL REGISTERED REPORT IDENTIFIERKidney diseaseRisk calculatorCare settingsBehaviour Change WheelChronic kidney disease awarenessChronic kidney disease guidelinesChronic kidney disease managementPrimary health care settingsKidney disease awarenessPre-post study designKidney disease managementKidney disease riskPrimary care settingClinical practice guidelinesOnline risk calculatorHealth care settingsBehavior changeDisease guidelinesImplementation science frameworkPatient populationClinician awarenessPatient awarenessPD38-07 PROMPT – PROSTATE GENETIC SCORE IMPROVES THE PERFORMANCE OF ESTABLISHED PROSTATE CANCER RISK CALCULATORS
Ghali* F, Ryan S, Ankerst D, Kattan M, Kader A. PD38-07 PROMPT – PROSTATE GENETIC SCORE IMPROVES THE PERFORMANCE OF ESTABLISHED PROSTATE CANCER RISK CALCULATORS. Journal Of Urology 2020, 203 DOI: 10.1097/ju.0000000000000917.07.Peer-Reviewed Original ResearchPerformance of the Vancouver Risk Calculator Compared with Lung-RADS in an Urban, Diverse Clinical Lung Cancer Screening Cohort
Kessler A, Peng R, Mardakhaev E, Haramati L, White C. Performance of the Vancouver Risk Calculator Compared with Lung-RADS in an Urban, Diverse Clinical Lung Cancer Screening Cohort. Radiology Imaging Cancer 2020, 2: e190021. PMID: 33778703, PMCID: PMC7983652, DOI: 10.1148/rycan.2020190021.Peer-Reviewed Original ResearchConceptsLung CT Screening ReportingLung-RADSFalse-negative findingsRadiology's Lung CT Screening ReportingLung cancer screening cohortAccountability Act-compliant retrospective studyLung cancer screening programsLung-RADS scoreInstitutional review board approvalCancer screening programsLung nodulesLung cancer screeningRisk of cancerReview board approvalDiverse clinical settingsMean followScreening cohortRetrospective studyRisk calculatorCancer screeningLung cancerScreening programStudy populationLung cancer detectionAmerican CollegePredicting toxicity-related docetaxel discontinuation and survival in metastatic castration-resistant prostate cancer (mCRPC) using open phase III trial data.
Parikh A, Martini A, Sfakianos J, Galsky M, Oh W, Tsao C. Predicting toxicity-related docetaxel discontinuation and survival in metastatic castration-resistant prostate cancer (mCRPC) using open phase III trial data. Journal Of Clinical Oncology 2020, 38: 75-75. DOI: 10.1200/jco.2020.38.6_suppl.75.Peer-Reviewed Original ResearchMetastatic castration-resistant prostate cancerRisk groupsMedian OSOverall survivalCumulative incidenceKaplan-MeierCastration-resistant prostate cancerPhase III trial dataControl armMedian Follow-UpECOG performance statusKaplan-Meier (KM) methodChronic kidney diseaseRisk calculatorProject Data SphereD′′ discontinuityDiagnosis of diabetesDocetaxel discontinuationDemographic/clinical dataPerformance statusProstate cancerPooled patientsFollow-upRisk regressionPrimary outcome
2019
“Radiotherapy for older women (ROW)”: A risk calculator for women with early-stage breast cancer
Wang SY, Abujarad F, Chen T, Evans SB, Killelea BK, Mougalian SS, Fraenkel L, Gross C. “Radiotherapy for older women (ROW)”: A risk calculator for women with early-stage breast cancer. Journal Of Geriatric Oncology 2019, 11: 850-859. PMID: 31899199, PMCID: PMC7263974, DOI: 10.1016/j.jgo.2019.12.010.Peer-Reviewed Original ResearchConceptsEarly-stage breast cancerRisk calculatorLocal recurrenceBreast cancerOlder womenTumor characteristicsBreast cancer-specific outcomesReceipt of radiotherapyCancer-specific outcomesEarly breast cancerIndividual patient's riskBenefits of radiotherapyAdvisory CommitteeLife expectancyOnline risk calculatorLong-term survivalShared decision makingBenefit of RTOlder adult womenRadiotherapy statusCause mortalityOverall survivalRecurrence reductionFunctional statusPatient riskRefining the American College of Surgeons NSQIP Surgical Risk Calculator to Include Geriatric Outcomes
Hornor M, Ma M, Zhou L, Cohen M, Rosenthal R, Russell M, Ko C. Refining the American College of Surgeons NSQIP Surgical Risk Calculator to Include Geriatric Outcomes. Journal Of The American College Of Surgeons 2019, 229: s121-s122. DOI: 10.1016/j.jamcollsurg.2019.08.272.Peer-Reviewed Original Research
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply